Clinical Trial Update: Long-term Study of Epiduo in Patients With Moderate to Severe Acne

View source ↗

Summary

Long-term clinical trial update for Epiduo in moderate-to-severe acne, noting that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• EPIDUO (adapalene and benzoyl peroxide)

Snippet

Sponsor: Galderma Laboratorium GmbH | Conditions: Acne Vulgaris | Status: COMPLETED